Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novelgenix Therapeutics is an early-stage biotechnology company focused on the discovery and development of innovative therapies for oncology and autoimmune disorders. The company leverages a proprietary drug discovery platform to identify novel targets and develop high-affinity therapeutic candidates, including small molecules and biologics. Based in India, Novelgenix aims to address significant unmet medical needs by streamlining the transition from lead optimization to clinical evaluation. Their current research efforts are centered on modulating key biological pathways involved in disease progression to provide more effective treatment options for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novelgenix Theraps.